Early hepatocellular carcinoma (BCLC 0 and A)

What changed: Early hepatocellular carcinoma (BCLC 0 and A)

Cancer page →

Every dated change on the records linked to Early hepatocellular carcinoma (BCLC 0 and A), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Trial result1Milestone6This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordEarly hepatocellular carcinoma (BCLC 0 and A)
Facts on this page last checked
When this page itself was last checked or edited.

2025 · 1

2025MilestoneIMbrave050
IMbrave050 update: the recurrence-free survival benefit is not sustained
A milestone in how this cancer is treated.

2023 · 2

2015 · 1

2015MilestoneSorafenib
STORM: adjuvant sorafenib fails after resection or ablation
A milestone in how this cancer is treated.

2006 · 1

2006MilestoneRadiofrequency ablation (RFA)
Randomised trial shows radiofrequency ablation equals resection for small tumours (Chen)
A milestone in how this cancer is treated.

1999 · 1

1999MilestoneBCLC staging
Barcelona Clinic Liver Cancer staging published (Llovet)
A milestone in how this cancer is treated.

1996 · 1

1996MilestoneLiver transplantation for cancer (Milan criteria and beyond)
Mazzaferro defines the Milan criteria for liver transplantation in HCC
A milestone in how this cancer is treated.